Efficacy and safety of mycophenolate mofetil in progressive multiple sclerosis patients.

Rami FakihMarcelo MatielloTanuja ChitnisJames M Stankiewicz

Published in: Journal of neurology (2018)

MMF did not affect disease progression but did influence relapse rate. We believe that other medication options should be considered before MMF in advanced progressive patients.

Keyphrases

multiple sclerosis
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
emergency department
patient reported
electronic health record